<abstract xmlns="http://www.w3.org/1999/xhtml">

Currently, nanoparticles have gained considerable attention for the treatment of bacterial infectious diseases. The possibility for using this technology as an alternative therapeutic strategy for controlling microbial biofilms, colonizations and infections has been the subject of intense investigations. Even though, the potential toxicity and disadvantage of using nanoparticles, researchers focused on their high penetrability into bacterial membranes, capabilities to disrupt biofilm formation and the role of chemotaxis in this interaction. Face to this significant debate, we discuss the link between metal resistance, bacterial chemotaxis and the promising use of nanoparticles (NP). <italic>P. aeruginosa</italic> has emerged as a model organism for biofilm studies, the aim of this review is to provide a concise and comprehensive survey of certain relevant aspects related to the research on nanoparticles and these bacteria.
</abstract>

The High Penetrability of Nanoparticles into Bacterial Membranes: A Key of a Potential Application

<abstract xmlns="http://www.w3.org/1999/xhtml">

Coxsackieviruses (CV), as all enteroviruses, are small, non-enveloped, icosahedral-shaped capsid viruses. They belong to the family <italic>Picornaviridae</italic>. This group was named after the town of Coxsackie in New York State (USA) where was recognized the first human case of coxsackievirus infection in the 40s of the XX century. Coxsackie B (CVB) are distinguished from other enteroviruses by ability to infect many types of tissues and organs. This wide tropism reason that these viruses are etiologic agents of large number of different diseases. CVB cause infection of the heart, pleura, pancreas, lungs and liver, causing myocarditis, pleurodynia, pericarditis, pneumonia and hepatitis. They can invade the central nervous system and induce meningitis, encephalitis, or acute flaccid paralysis. They also cause systemic neonatal disease and chronic infections such as type 1 diabetes and chronic myocarditis. This pantropic character of CVB can be determinate by specific virus – receptor interaction, which initiate the infection and viral spread. CVB attach at least two receptor proteins: the coxsackievirus – adenovirus receptor (CAR) and the decay – accelerating factor (DAF). Moreover, other anonymous determinant may play a role in tissue permissiveness and disease severity. This article summarizes the main aspects of Coxsackieviruses B infection: replication, virus-receptor interaction, genetic variability, pathogenesis, epidemiology and diagnostics.
</abstract>

Coxsackie B – Pantropic Viruses

<abstract xmlns="http://www.w3.org/1999/xhtml">

<italic>Candida auris</italic> is a new fungal pathogen whose clinical significance has dramatically increased within recent years. Major issues related to this species include its rapid global spread and high epidemic potential, resilience and persistence in the hospital environment favoured by its resistance against certain disinfectants, horizontal transmission; possibility of persistent colonization, challenging laboratory identification based on conventional biochemical methods, multidrug resistance as well as the need for implementation of restrictive and expensive prevention and control measures. This review raises the above mentioned issues and compiles recent findings regarding this microorganism.
</abstract>

<italic>Candida Auris</italic>: What do We Know about the Most Enigmatic Pathogen of the 21st Century?

<abstract xmlns="http://www.w3.org/1999/xhtml">

Lipopolysaccharide (LPS) is found in most Gram-negative bacteria and induces innate responses by binding to toll-like receptor 4 (TLR4). LPS isolated from <italic>Pantoea agglomerans</italic> species is an interesting issue. On the one hand, it is a risk factor for diseases such as wounds, abscess, bacteremia, pneumonia, urinary tract infections, septic arthritis, osteomyelitis and peritonitis. On the other, its health-promoting properties in atherosclerosis, Alzheimer’s disease, and osteoporosis are increasingly observed. Studies in humans and animal models show that LPS from <italic>P. agglomerans</italic> may have beneficial effects in the treatment of certain diseases. A huge challenge today is the prevention and treatment of skin diseases, including atopic dermatitis (AD), allergic contact dermatitis (ACD), and hard-to-heal wounds. Reports show that LPS from <italic>P. agglomerans</italic> may be useful in the treatment of skin diseases through its effects on the immune response. Studies show that LPS acts on Langerhans cells and leads to suppression of the allergic response.
</abstract>

Lipopolysaccharide <italic>Pantoea Agglomerans</italic> and Atopic Dermatitis, Allergic Contact Dermatitis and Wound Healing

<abstract xmlns="http://www.w3.org/1999/xhtml">

In order to meet the growing needs of the world economy for biotechnology, culture collections must transform the way they operate from passive storage of microbial resources to active microbial resource centers whose services should go beyond the provision of microbes. The protection and conscious use of microorganisms aims to co-create a strategy for responsible and sustainable development, based on expert knowledge. This article deals with the subject of the recently developed panel of biobank-specific standards and the requirements that must be met by culture collections to transform into modern microbial biobanks.
</abstract>

Microbial Culture Collections and Microbiological Biobanks in the Context of New ISO Standards

AHEAD OF PRINT

Volume 63 (2024): Issue 1 (March 2024)

Volume 62 (2023): Issue 3-4 (November 2023)

Volume 62 (2023): Issue 2 (June 2023)

Volume 62 (2023): Issue 1 (March 2023)

Volume 61 (2022): Issue 4 (December 2022)

Volume 61 (2022): Issue 3 (September 2022)

Volume 61 (2022): Issue 2 (June 2022)

Volume 61 (2022): Issue 1 (March 2022)

Volume 60 (2021): Issue 4 (December 2021)

Volume 60 (2021): Issue 3 (January 2021)

Volume 60 (2021): Issue 2 (January 2021)

Volume 60 (2021): Issue 1 (January 2021)

Volume 59 (2020): Issue 4 (December 2020)

Volume 59 (2020): Issue 3 (January 2020)

Volume 59 (2020): Issue 2 (January 2020)

Volume 59 (2020): Issue 1 (January 2020)

Volume 58 (2019): Issue 4 (January 2019)

Volume 58 (2019): Issue 3 (January 2019)

Volume 58 (2019): Issue 2 (January 2019)

Volume 58 (2019): Issue 1 (January 2019)

Volume 57 (2018): Issue 4 (January 2018)

Volume 57 (2018): Issue 3 (January 2018)

Volume 57 (2018): Issue 2 (January 2018)

Volume 57 (2018): Issue 1 (January 2018)

Volume 56 (2017): Issue 4 (January 2017)

Volume 56 (2017): Issue 3 (January 2017)

Volume 56 (2017): Issue 2 (January 2017)

Volume 56 (2017): Issue 1 (January 2017)

Advancements of Microbiology

 The Advancements of Microbiology (formerly Postępy Mikrobiologii) is a quarterly of the Polish Society of Microbiologists. The journal was founded in 1961, initially under the patronage of the Microbiology Committee of the Polish Academy of Sciences, and in 1989 it became the organ of the PSM. The following professors have served as Editors-in-Chief of Postępy Mikrobiologii during the period: Prof. Edmund Mikulaszek 1962 – 1972, Prof. Władysław Tomasz Dobrzański 1972 – 1982, Prof. Zdzislaw Ilczuk 1983 – 1991, Prof. Jerzy Hrebenda 1991 – 2009, Prof. Jacek Bielecki 2009 – 2022. Journal implements the Society’s main goals, like promoting the development of microbiological sciences, popularizing the achievements of microbiology among members of the Society and broad circles of readers.   Advancements of Microbiology is topical journal for scientists in several microbiological fields and often the place where the first works of young researchers are published. Advancements of Microbiology include review articles from all areas of microbiology that are not printed in other journals. Please send manuscripts with attachments to the editor's e-mail address: editorial.office@am-online.org   Due to the great thematic diversity of the articles sent to the editorial office, it is not possible to print monographic volumes. Most of the papers currently published in Advancements of Microbiology are review articles in the field of bacterial physiology, microbial genetics, environmental microbiology, applied microbiology and virology; the work in the field of epidemiology, classification and identification of bacteria and applications of molecular biology techniques in microbiological research are particularly extensive.   The editors of Advancements of Microbiology strive to print works – ordered by eminent scientists – regarding currently fashionable problems of modern science. We especially encourage Authors to write articles in the field of their expertise, which guarantees the highest scientific level. The high scientific level of the journal was reflected in the progress of the JCR citation index and the presence of our journal on the Philadelphia list. It is especially important for young Authors, for whom Advancements of Microbiology often open the way to a scientific career. The current activity of Advancements of Microbiology is based mainly on publishing reviews related to the latest scientific achievements in the field of microbiology, which, at present is characterized by unusual dynamics of development and comprehensive application possibilities. The selection of current and relevant research topics and their presentation at a high scientific level in our journal is the basis for the existence of the quarterly, Advancements of Microbiology.   Open Access Policy   This journal provides immediate open access to its content under the Creative Commons CC BY-NC-ND 4.0 license　on the principle that making research freely available to the public supports a greater global exchange of knowledge. Under the CC BY-NC-ND 4.0 license users are free to share the work (copy and redistribute the material in any medium or format), if the contribution is properly attributed and used for non-commercial purposes. The material published in the journal may not be altered or built upon.   ABOUT SOCIETY   The origin of microbiology in Poland goes back to the XIX century. Professor Odo Feliks Kazimierz Bujwid (1857 – 1942) – was the first Polish bacteriologist, who graduated from the University of Warsaw and gained experience in Berlin working with Robert Koch, and in Paris at the Ludwik Pasteur Institute.   The Polish Society of Microbiologists (PSM), formerly the Polish Society of Microbiologists and Epidemiologists, was established in Warsaw on October 31, 1927 at the first Congress of Polish microbiologists. Professor Zygmunt Szymanowski was elected the first President of PSM. The same year, PSM also became cofounder of Federation of European Microbiological Societies (FEMS) and since 2005 PSM is a member of European Society of Clinical Microbiology and Infectious Diseases (ESCMID).   Within over 95 years of activity, 29 Congresses of PSM were organized and 16 professors were elected as Presidents of PSM. About 900 ordinary members and 19 honorary members, associated in 14 PSM branches all over Poland, belong to the Society.   The aims of PSM have been the same since its very beginnings: to promote the development of microbiological sciences and to popularize the achievements of microbiology among the Society’s members and the broad public. PSM organizes congresses, scientific meetings, courses and lectures and competitions of scientific papers. Two quarterly journals, the Polish Journal of Microbiology and the Advancements in Microbiology are issued by PSM. The Society formulates opinions on the conditions and needs of Polish microbiology and applies in these cases to the state authorities; cooperates with related associations in the country and abroad.   Archiving   Sciendo archives the contents of this journal in Portico – a digital long-term preservation service of scholarly books, journals and collections.   Plagiarism Policy   The editorial board is participating in a growing community of Similarity Check System’s users to ensure that the content published is original and trustworthy. Similarity Check is a medium that allows for comprehensive manuscripts screening, aimed to eliminate plagiarism and provide a high standard and quality peer-review process. 

Advancements of Microbiology

Volume 62 (2023): Issue 1 (March 2023)

The High Penetrability of Nanoparticles into Bacterial Membranes: A Key of a Potential Application

Coxsackie B – Pantropic Viruses

Candida Auris: What do We Know about the Most Enigmatic Pathogen of the 21^st Century?

Lipopolysaccharide Pantoea Agglomerans and Atopic Dermatitis, Allergic Contact Dermatitis and Wound Healing

Microbial Culture Collections and Microbiological Biobanks in the Context of New ISO Standards

Chercher

Tous les volumes et éditions dans cette revue

Advancements of Microbiology

Volume 62 (2023): Issue 1 (March 2023)

The High Penetrability of Nanoparticles into Bacterial Membranes: A Key of a Potential Application

Coxsackie B – Pantropic Viruses

Candida Auris: What do We Know about the Most Enigmatic Pathogen of the 21st Century?

Lipopolysaccharide Pantoea Agglomerans and Atopic Dermatitis, Allergic Contact Dermatitis and Wound Healing

Microbial Culture Collections and Microbiological Biobanks in the Context of New ISO Standards

Chercher

Tous les volumes et éditions dans cette revue

Candida Auris: What do We Know about the Most Enigmatic Pathogen of the 21^st Century?